Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DocGo (DCGO) Common Equity: 2020-2025

Historic Common Equity for DocGo (DCGO) over the last 6 years, with Q3 2025 value amounting to $270.5 million.

  • DocGo's Common Equity fell 1673.45% to $270.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.5 million, marking a year-over-year decrease of 1673.45%. This contributed to the annual value of $320.9 million for FY2024, which is 515.99% up from last year.
  • DocGo's Common Equity amounted to $270.5 million in Q3 2025, which was down 1673.45% from $297.3 million recorded in Q2 2025.
  • Over the past 5 years, DocGo's Common Equity peaked at $324.9 million during Q3 2024, and registered a low of $65.7 million during Q1 2021.
  • For the 5-year period, DocGo's Common Equity averaged around $252.2 million, with its median value being $283.9 million (2023).
  • Its Common Equity has fluctuated over the past 5 years, first soared by 29230732.5% in 2021, then plummeted by 1673.45% in 2025.
  • DocGo's Common Equity (Quarter) stood at $227.1 million in 2021, then grew by 22.84% to $278.9 million in 2022, then grew by 9.41% to $305.2 million in 2023, then increased by 5.16% to $320.9 million in 2024, then decreased by 15.7% to $270.5 million in 2025.
  • Its Common Equity stands at $270.5 million for Q3 2025, versus $297.3 million for Q2 2025 and $309.3 million for Q1 2025.